
Simulations Plus Announces Second Quarter Fiscal 2026 Financial Results
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results, Highlighting Revenue Growth and Strong Software Performance Simulations Plus, Inc. (Nasdaq: SLP), a global leader in model-informed drug development (MIDD) and AI-accelerated solutions for the biopharmaceutical industry, today announced its financial…













